127 related articles for article (PubMed ID: 8578698)
1. [Etofylline clofibrate in the treatment of diabetic dyslipidemia: results of a 6-month period of therapy].
Rajecová E; Klimes I; Seböková E; Rychnavská E; Pleváková L; Linke-Cvrkalová A; Langrová H
Vnitr Lek; 1995 Oct; 41(10):677-81. PubMed ID: 8578698
[TBL] [Abstract][Full Text] [Related]
2. [Duolip Forte--experience during a 6-month period of administration].
Toschnerová H; Ceska R; Sobra J; Traurig J
Cas Lek Cesk; 1993 May; 132(10):308-10. PubMed ID: 8513467
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Vorberg G; Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects and tolerance of etofylline clofibrate].
Ziegler WJ; Metz G; Specker M
Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
[TBL] [Abstract][Full Text] [Related]
5. [Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia].
Hrebícek J; Skottová N; Chmela Z; Hrbková M
Cas Lek Cesk; 1995 Mar; 134(5):141-4. PubMed ID: 7728839
[TBL] [Abstract][Full Text] [Related]
6. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
Ditschuneit HH; Hutt V; Klör HU; Ditschuneit H
Arzneimittelforschung; 1980; 30(11b):2063-7. PubMed ID: 7194061
[TBL] [Abstract][Full Text] [Related]
7. [Etophylline clofibrate in the treatment of familial combined hyperlipoproteinemia].
Raslová K; Hucková M
Vnitr Lek; 1995 Apr; 41(4):240-2. PubMed ID: 7762188
[TBL] [Abstract][Full Text] [Related]
8. [Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
Skrha J; Sindelka G; Haas T; Hilgertová J; Justová V
Cas Lek Cesk; 1994 Aug; 133(16):496-9. PubMed ID: 7923327
[TBL] [Abstract][Full Text] [Related]
9. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
Bolzano K; Krempler F; Schellenberg B; Schlierf G
Acta Med Austriaca; 1979; 6(3):90-4. PubMed ID: 547652
[TBL] [Abstract][Full Text] [Related]
10. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
11. [Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
Altomonte L; Mingrone G; Ghirlanda G; Manna R; Rebuzzi A; Pala MA; Greco AV
Minerva Med; 1980 Feb; 71(4):273-8. PubMed ID: 7354946
[TBL] [Abstract][Full Text] [Related]
12. [Etolip and Lipanthyl in the treatment of hyperlipoproteinemia].
Ceska R; Sobra J; Procházková R; Kvasilová M
Vnitr Lek; 1990 Apr; 36(4):363-7. PubMed ID: 2356612
[TBL] [Abstract][Full Text] [Related]
13. [Plafibride treatment of hyperlipidemias type II and IV].
Soler J; Vinzia C; Gómez JM; Morató J
Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212
[No Abstract] [Full Text] [Related]
14. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
Lopez Rodriguez J; Martorell J
Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hyperlipoproteinemia type II with etofibrate.
Gustafson A
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):498-502. PubMed ID: 528096
[TBL] [Abstract][Full Text] [Related]
17. Plafibride treatment and serum lipids in hyperlipoproteinemias.
Rodriguez F; López IM; Jover E
J Med; 1987; 18(3-4):153-63. PubMed ID: 3323393
[TBL] [Abstract][Full Text] [Related]
18. [Therapy with fibrates and vitamin D metabolism].
Wilczek H; Sobra J; Ceska R; Justová V; Procházková R; Kvasilová M; Jůzová Z
Cas Lek Cesk; 1993 Oct; 132(20):630-2. PubMed ID: 8269466
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with bezafibrate.
Schubotz R; Schneider J; Hausmann L; Mühlfellner G; Mühlfellner O; Kaffarnik H
Artery; 1980; 8(6):553-9. PubMed ID: 7259534
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
Schwartzkopff W; Luley C; Scheffler W; Lehmann-Leo W; Schilling A; Wegscheider K
Med Welt; 1982 Apr; 33(17):631-7. PubMed ID: 7098826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
